785 related articles for article (PubMed ID: 29162310)
1. Therapeutic Mechanisms of Glucocorticoids.
Vandewalle J; Luypaert A; De Bosscher K; Libert C
Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
[TBL] [Abstract][Full Text] [Related]
2. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
Dejager L; Vandevyver S; Petta I; Libert C
Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
[TBL] [Abstract][Full Text] [Related]
3. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
4. Targeting inflammation using selective glucocorticoid receptor modulators.
De Bosscher K; Haegeman G; Elewaut D
Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
[TBL] [Abstract][Full Text] [Related]
5. Non-genomic Effects of Glucocorticoids: An Updated View.
Panettieri RA; Schaafsma D; Amrani Y; Koziol-White C; Ostrom R; Tliba O
Trends Pharmacol Sci; 2019 Jan; 40(1):38-49. PubMed ID: 30497693
[TBL] [Abstract][Full Text] [Related]
6. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
Ingawale DK; Mandlik SK; Patel SS
J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
[TBL] [Abstract][Full Text] [Related]
7. Optimized glucocorticoid therapy: teaching old drugs new tricks.
Strehl C; Buttgereit F
Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
[TBL] [Abstract][Full Text] [Related]
8. The search for safer glucocorticoid receptor ligands.
Rosen J; Miner JN
Endocr Rev; 2005 May; 26(3):452-64. PubMed ID: 15814846
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.
Buttgereit F; Saag KG; Cutolo M; da Silva JA; Bijlsma JW
Scand J Rheumatol; 2005; 34(1):14-21. PubMed ID: 15903020
[TBL] [Abstract][Full Text] [Related]
10. Dissociated glucocorticoid receptor ligands.
Schäcke H; Rehwinkel H
Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
[TBL] [Abstract][Full Text] [Related]
11. Molecular interaction between the glucocorticoid receptor and MAPK signaling pathway: a novel link in modulating the anti-inflammatory role of glucocorticoids.
Kharwanlang B; Sharma R
Indian J Biochem Biophys; 2011 Aug; 48(4):236-42. PubMed ID: 22053692
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids.
Spies CM; Strehl C; van der Goes MC; Bijlsma JW; Buttgereit F
Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):891-900. PubMed ID: 22265268
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid resistance as a major drive in sepsis pathology.
Dendoncker K; Libert C
Cytokine Growth Factor Rev; 2017 Jun; 35():85-96. PubMed ID: 28479044
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Glucocorticoid Receptor in Acute Inflammation: the SEDIGRAM Concept.
De Bosscher K; Beck IM; Ratman D; Berghe WV; Libert C
Trends Pharmacol Sci; 2016 Jan; 37(1):4-16. PubMed ID: 26603477
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in glucocorticoid resistance.
Yang N; Ray DW; Matthews LC
Steroids; 2012 Sep; 77(11):1041-9. PubMed ID: 22728894
[TBL] [Abstract][Full Text] [Related]
17. New insights into the novel anti-inflammatory mode of action of glucocorticoids.
Ingawale DK; Mandlik SK
Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):59-73. PubMed ID: 32070175
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
Hapgood JP; Avenant C; Moliki JM
Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
[TBL] [Abstract][Full Text] [Related]
19. It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions.
Nixon M; Andrew R; Chapman KE
Steroids; 2013 Jan; 78(1):59-68. PubMed ID: 23127816
[TBL] [Abstract][Full Text] [Related]
20. Why do we need nongenomic glucocorticoid mechanisms?
Jiang CL; Liu L; Tasker JG
Front Neuroendocrinol; 2014 Jan; 35(1):72-5. PubMed ID: 24103541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
